Mitsubishi UFJ Morgan Stanley Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Mitsubishi UFJ Morgan Stanley Securities's PFE Position: Q1 2023 in Review
Mitsubishi UFJ Morgan Stanley Securities sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,120 shares — an estimated $211K sold.
Mitsubishi UFJ Morgan Stanley Securities first reported a position in PFE in Q2 2013 and held it in 14 quarters. The position peaked at $236K in Q4 2021. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- Mitsubishi UFJ Morgan Stanley Securities reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
- Mitsubishi UFJ Morgan Stanley Securities sold 4,120 Pfizer shares in Q1 2023, an estimated $211K.
- Mitsubishi UFJ Morgan Stanley Securities first reported a position in Pfizer in Q2 2013 and held it in 14 quarters.
- Mitsubishi UFJ Morgan Stanley Securities's Pfizer position peaked at $236K in Q4 2021.
- 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q1 2023, filed 2 May 2023.